Drug law versus common parlance of medicinal chemists on “new chemical entity” of novel drug designations
Medicinal Chemistry Research · 2026-05 · 35 (5) · 863-866
DOI: 10.1007/s00044-026-03546-1 ↗Kurz gefasst
Editorial in der Zeitschrift Medicinal Chemistry Research, online erschienen am 09.04.2026. Verfasst von Sarah K Branch und 1 weiteren Autor:innen. Beteiligte Einrichtung: , Gravesend, UK. sarahbranch2022@gmail.com. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- , Gravesend, UK. sarahbranch2022@gmail.com.
- Organic Chemistry, Institute of Chemistry, Philadelphia Building #212, Edmond J. Safra Campus, The Hebrew University of Jerusalem, Jerusalem, Israel. isri.agranat@mail.huji.ac.il.
Zitieren
APA
Branch, S. K., & Agranat, I. (2026). Drug law versus common parlance of medicinal chemists on “new chemical entity” of novel drug designations. Medicinal Chemistry Research, 35(5), 863-866. https://doi.org/10.1007/s00044-026-03546-1
Vancouver
Branch SK, Agranat I. Drug law versus common parlance of medicinal chemists on “new chemical entity” of novel drug designations. Medicinal Chemistry Research. 2026;35(5):863-866. doi:10.1007/s00044-026-03546-1
BibTeX
@article{Branch2026,
author = {Branch, Sarah K and Agranat, Israel},
title = {Drug law versus common parlance of medicinal chemists on “new chemical entity” of novel drug designations},
journal = {Medicinal Chemistry Research},
year = {2026},
volume = {35},
number = {5},
pages = {863--866},
doi = {10.1007/s00044-026-03546-1}
}
EUVIMED